|
Volume
19 Number 12
31 December 2017
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
19, Year 2017 >
Number 12, 31 December
|
|
|
|
|
|
Karpel-Massler G, Siegelin MD.
TIC10/ONC201-a
potential therapeutic in glioblastoma.
Transl
Cancer Res. 2017 Dec;6(Suppl 9):S1439-S1440→.
doi: 10.21037/tcr.2017.10.51→.
PMID:
30148071→.
Comment.
ˍ
Refers
to:
Arrillaga-Romany
I, et
al.,
A phase 2 study of the first imipridone ONC201, a selective DRD2
antagonist for oncology, administered every three weeks in
recurrent glioblastoma.
Oncotarget. 2017 May 12,
2017;8(45):79298-79304→.
doi: 10.18632/oncotarget.17837→.
PMID: 29108308→.
Interventional
study. ˍ
|
|
|
|
Krauze A, Attia A, Braunstein S,
Chan M, Combs S, Fietkau R, Fiveash J, Flickinger J, Grosu A,
Howard S, Nieder C, Niyazi M, Rowe L, Smart DD, Tsien C,
Camphausen K.
Expert
consensus on re-irradiation for recurrent glioma.
Radiat
Oncol. 2017 Dec 1, 2017;12(1):194→.
doi: 10.1186/s13014-017-0928-3→.
PMID:
29195507→.
Observational
study. ˍ
|
|
|
|
Patel CK, Vemaraju R, Glasbey J,
Shires J, Northmore T, Zaben M, Hayhurst C.
Trends
in peri-operative performance status following resection of high
grade glioma and brain metastases: The impact on survival.
Clin
Neurol Neurosurg. 2017 Dec 1, 2018;164:67-71→.
doi: 10.1016/j.clineuro.2017.11.016→.
PMID:
29197281→.
Observational study. ˍ
|
|
|
|
Picart T, Barritault M, Berthillier
J, Meyronet D, Vasiljevic A, Frappaz D, Honnorat J, Jouanneau E,
Poncet D, Ducray F, Guyotat J.
Characteristics
of cerebellar glioblastomas in adults.
J
Neurooncol. 2017 Dec 1, 2018;136(3):555-563→.
doi: 10.1007/s11060-017-2682-7→.
PMID: 29196927→.
Observational
study. ˍ
|
|
|
|
Zapotocky M, Mata-Mbemba D,
Sumerauer D, Liby P, Lassaletta A, Zamecnik J, Krskova L, Kyncl M,
Stary J, Laughlin S, Arnoldo A, Hawkins C, Tabori U, Taylor MD,
Bouffet E, Raybaud C, Ramaswamy V.
Differential
patterns of metastatic dissemination across medulloblastoma
subgroups.
J
Neurosurg Pediatr. 2017 Dec 8, 2018;21(2):145-152→.
doi: 10.3171/2017.8.PEDS17264→.
PMID: 29219788→.
Observational study. ˍ
Ramaswamy
V. Erratum.
Differential patterns of
metastatic dissemination across medulloblastoma subgroups.
J
Neurosurg Pediatr. 2018 Jan 5, 2018;21(3):336→.
doi: 10.3171/2017.12.PEDS17264a→.
PMID: 29303460→.
Correction. ˍ
|
|
|
|
Pellegatta S, Eoli M, Cuccarini V, Anghileri E, Pollo B, Pessina
S, Frigerio S, Servida M, Cuppini L, Antozzi C, Cuzzubbo S,
Corbetta C, Paterra R, Acerbi F, Ferroli P, DiMeco F, Fariselli L,
Parati EA, Bruzzone MG, Finocchiaro G.
Survival
gain in glioblastoma patients treated with dendritic cell
immunotherapy is associated with increased NK but not CD8+
T cell activation in the presence
of adjuvant temozolomide.
Oncoimmunology. 2017 Dec
7, 2018;7(4):e1412901→.
doi: 10.1080/2162402X.2017.1412901→.
PMID: 29632727→.
Interventional
study. ˍ
|
|
|
|
Houdova Megova M, Drábek J,
Dwight Z, Trojanec R, Koudeláková V, Vrbková
J, Kalita O, Mlcochova S, Rabcanova M, Hajdúch M.
Isocitrate
Dehydrogenase Mutations are Better Prognostic Marker than
O6-methylguanine-DNA Methyltransferase Promoter Methylation in
Glioblastomas - a Retrospective, Single-centre Molecular Genetics
Study of Gliomas.
Klin
Onkol. 2017 Dec 9, 2017 Fall;30(5):361-371→.
doi: 10.14735/amko2017361? PMID:
29031038→.
Observational
study. ˍ
|
|
|
|
Calmon R, Puget S, Varlet P,
Dangouloff-Ros V, Blauwblomme T, Beccaria K, Grevent D,
Sainte-Rose C, Castel D, Debily MA, Dufour C, Bolle S, Dhermain F,
Saitovitch A, Zilbovicius M, Brunelle F, Grill J, Boddaert N.
Cerebral
blood flow changes after radiation therapy identifies
pseudo-progression in diffuse intrinsic pontine gliomas.
Neuro
Oncol. 2017 Dec 13, 2018;20(7):994-1002→.
doi: 10.1093/neuonc/nox227→.
PMID: 29244086→.
Observational
study. ˍ
|
|
|
|
Foreman PM, Jackson BE, Singh KP,
Romeo AK, Guthrie BL, Fisher WS, Riley KO, Markert JM, Willey CD,
Bredel M, Fiveash JB.
Postoperative
radiosurgery for the treatment of metastatic brain tumor:
Evaluation of local failure and leptomeningeal disease.
J
Clin Neurosci. 2017 Dec 13, 2018;49:48-55→.
doi: 10.1016/j.jocn.2017.12.009→.
PMID: 29248376→.
Observational
study. ˍ
|
|
|
|
Mahlokozera T, Vellimana AK, Li
T, Mao DD, Zohny ZS, Kim DH, Tran DD, Marcus DS, Fouke SJ, Campian
JL, Dunn GP, Miller CA, Kim AH.
Biological
and therapeutic implications of multisector sequencing in newly
diagnosed glioblastoma.
Neuro Oncol. 2017 Dec 13,
2018;20(4):472-483→.
doi: 10.1093/neuonc/nox232→.
PMID: 29244145→.
Laboratory investigation. ˍ
|
|
|
|
Muscat AM, Wong NC, Drummond KJ,
Algar EM, Khasraw M, Verhaak R, Field K, Rosenthal MA, Ashley DM.
The
evolutionary pattern of mutations in glioblastoma reveals
therapy-mediated selection.
Oncotarget.
2017 Dec 15, 2017;9(8):7844-7858→.
doi: 10.18632/oncotarget.23541→.
PMID:
29487696→.
Laboratory
investigation. ˍ
|
|
|
.
|
Moraes FY, Lo A, Morgan ER, Millar
BA, Shultz DB, Maurice C, Harlos C, Kongkham P, Bernstein M, Zadeh
G, Laperriere N, Mason W, Berlin A.
Management
and Outcomes in the Oldest-Old Population with Glioblastoma.
Can
J Neurol Sci. 2017 Dec 18, 2018;45(2):199-205→.
doi: 10.1017/cjn.2017.278→.
PMID:
29249210→.
Observational
study. ˍ
|
|
|
|
Stupp R, Taillibert S, Kanner A,
Read W, Steinberg DM, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS,
Fink K, Di Meco F, Lieberman F, Zhu JJ, Stragliotto G, Tran DD,
Brem S, Hottinger AF, Kirson ED, Lavy-Shahaf G, Weinberg U, Kim
CY, Paek SH, Nicholas G, Burna J, Hirte H, Weller M, Palti Y, Hegi
ME, Ram Z.
Effect
of Tumor-Treating Fields Plus Maintenance Temozolomide vs
Maintenance Temozolomide Alone on Survival in Patients With
Glioblastoma: A Randomized Clinical Trial.
JAMA.
2017 Dec 19, 2017;318(23):2306-2316→.
doi: 10.1001/jama.2017.18718→.
PMID:
29260225→.
Interventional
study. ˍ
|
|
|
.
|
O'Regan CJ, Kearney H, Beausang A,
Farrell MA, Brett FM, Cryan JB, Loftus TE, Buckley PG.
Temporal
stability of MGMT promoter methylation in glioblastoma patients
undergoing STUPP protocol.
J
Neurooncol. 2017 Dec 20, 2018;137(2):233-240→.
doi: 10.1007/s11060-017-2722-3→.
PMID:
29264834→.
Laboratory
investigation. ˍ
|
|
|
|
Smith DR, Wu CC, Saadatmand HJ,
Isaacson SR, Cheng SK, Sisti MB, Bruce JN, Sheth SA, Lassman AB,
Iwamoto FM, Wang SH, Canoll P, McKhann GM Nd, Wang TJC.
Clinical
and molecular characteristics of gliosarcoma and modern prognostic
significance relative to conventional glioblastoma.
J
Neurooncol. 2017 Dec 20, 2018;137(2):303-311→.
doi: 10.1007/s11060-017-2718-z→.
PMID: 29264835→.
Observational
study. ˍ
|
|
|
|
Gorlia T, van den Bent MJ, Hegi ME,
Mirimanoff RO, Weller M, Cairncross JG, Eisenhauer E, Belanger K,
Brandes AA, Allgeier A, Lacombe D, Stupp R.
Nomograms
for predicting survival of patients with newly diagnosed
glioblastoma: prognostic factor analysis of EORTC and NCIC trial
26981-22981/CE.3.
Lancet
Oncol. 2007 Dec 21, 2008;9(1):29-38→.
doi: 10.1016/S1470-2045(07)70384-4→.
PMID: 18082451→.
Observational
study. ˍ
|
|
|
|
Padovani L, Chapon F, André
N, Boucekine M, Geoffray A, Bourdeau F, Masliah-Planchon J, Claude
L, Huchet A, Laprie A, Supiot S, Coche-Dequéant B, Kerr C,
Alapetite C, Leseur J, Nguyen T, Chapet S, Bernier V, Bondiau PY,
Noel G, Habrand JL, Bolle S, Doz F, Dufour C, Muracciole X, Carrie
C.
Hippocampal
Sparing During Craniospinal Irradiation: What Did We Learn About
the Incidence of Perihippocampus Metastases?
Int
J Radiat Oncol Biol Phys. 2017 Dec 21, 2018;100(4):980-986→.
doi: 10.1016/j.ijrobp.2017.12.265→.
PMID: 29485078→.
Observational study. ˍ
|
|
|
.
|
Peters KB, Lipp ES, Miller E,
Herndon JE 2nd, McSherry F, Desjardins A, Reardon DA, Friedman HS.
Phase
I/II trial of vorinostat, bevacizumab, and daily temozolomide for
recurrent malignant gliomas.
J
Neurooncol. 2017 Dec 21, 2018;137(2):349-356→.
doi: 10.1007/s11060-017-2724-1→.
PMID: 29264836→.
Interventional
study. ˍ
|
|
|
|
Attal J, Chaltiel L, Lubrano V, Sol
JC, Lanaspeze C, Vieillevigne L, Latorzeff I, Cohen-Jonathan Moyal
E.
Subventricular
zone involvement at recurrence is a strong predictive factor of
outcome following high grade glioma reirradiation.
J
Neurooncol. 2017 Dec 22, 2018;136(2):413-419→.
doi: 10.1007/s11060-017-2669-4→.
PMID:
29273890→.
Observational
study. ˍ
|
|
|
.
|
Deuschl C, Kirchner J, Poeppel TD,
Schaarschmidt B, Kebir S, El Hindy N, Hense J, Quick HH, Glas M,
Herrmann K, Umutlu L, Moenninghoff C, Radbruch A, Forsting M,
Schlamann M.
11C-MET
PET/MRI for detection of recurrent glioma.
Eur
J Nucl Med Mol Imaging. 2017 Dec 28, 2018;45(4):593-601→.
doi: 10.1007/s00259-017-3916-9→.
PMID:
29282517→.
Interventional
study. ˍ
|
|
|
.
|
Kits A, Martin H, Sanchez-Crespo A,
Delgado AF.
Diagnostic
accuracy of 11C-methionine
PET in detecting neuropathologically confirmed recurrent brain
tumor after radiation therapy.
Ann
Nucl Med. 2017 Dec 26, 2018;32(2):132-141→.
doi: 10.1007/s12149-017-1227-7→.
PMID:
29280066→.
Observational
study. ˍ
|
|
|
|
|
|
|
|
|
